Targeting HER2-positive breast cancer: advances and future directions
Sandra M. SwainDepartment of Medicine, Georgetown Lombardi Comprehensive Cancer Center and MedStar Health, Washington, DC, USA. [email protected]Mythili ShastrySarah Cannon Research Institute, Nashville, TN, USAErika HamiltonSarah Cannon Research Institute, Nashville, TN, USA
2022en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
3 та иқтибос0 та фойдаланилган манба